POWERED BY DEHYDRATECH Trademark

Trademark Overview

On Thursday, October 28, 2021, a trademark application was filed for POWERED BY DEHYDRATECH with the United States Patent and Trademark Office. The USPTO has given the POWERED BY DEHYDRATECH trademark a serial number of 97097082. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, November 21, 2024. This trademark is owned by Lexaria Bioscience Corp.. The POWERED BY DEHYDRATECH trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery systems, namely drug delivery agents, in solid oral, liquid oral, oral spray, nasal spray, suppository, topical mucosal, topical dermal and topical transdermal formats, utilizing a dehydration process, for the purpose of fast and sustained release of fat-soluble bioactive molecules, increased bioavailability of fat-soluble bioactive molecules, increased brain absorption of fat-soluble bioactive molecules and masking the unwanted tastes of fat-soluble bioactive molecules all as incorporated as an integral component of pharmaceutical preparations; drug delivery systems, namely drug delivery agents, in solid oral, liquid oral, oral spray, nasal spray, suppository, topical mucosal, topical dermal and topical transdermal formats, utilizing a dehydration process, for the purpose of fast and sustained release of fat-soluble bioactive molecules, increased bioavailability of fat-soluble bioactive molecules, increased brain absorption of fat-soluble bioactive molecules and masking ...

General Information

Serial Number97097082
Word MarkPOWERED BY DEHYDRATECH
Filing DateThursday, October 28, 2021
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDrug delivery systems, namely drug delivery agents, in solid oral, liquid oral, oral spray, nasal spray, suppository, topical mucosal, topical dermal and topical transdermal formats, utilizing a dehydration process, for the purpose of fast and sustained release of fat-soluble bioactive molecules, increased bioavailability of fat-soluble bioactive molecules, increased brain absorption of fat-soluble bioactive molecules and masking the unwanted tastes of fat-soluble bioactive molecules all as incorporated as an integral component of pharmaceutical preparations; drug delivery systems, namely drug delivery agents, in solid oral, liquid oral, oral spray, nasal spray, suppository, topical mucosal, topical dermal and topical transdermal formats, utilizing a dehydration process, for the purpose of fast and sustained release of fat-soluble bioactive molecules, increased bioavailability of fat-soluble bioactive molecules, increased brain absorption of fat-soluble bioactive molecules and masking the unwanted tastes of fat-soluble bioactive molecules all as incorporated as an integral component of non-pharmaceutical consumer goods

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLexaria Bioscience Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhoenix, AZ 85021

Trademark Events

Event DateEvent Description
Monday, November 1, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 8, 2022ASSIGNED TO EXAMINER
Tuesday, August 16, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 16, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 18, 2022SUSPENSION LETTER WRITTEN
Tuesday, October 18, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, October 18, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 25, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 30, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 30, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, May 30, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, October 27, 2023ASSIGNED TO LIE
Sunday, October 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 28, 2023SUSPENSION LETTER WRITTEN
Tuesday, November 28, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, November 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 25, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, November 19, 2024INQUIRY TO SUSPENSION E-MAILED
Tuesday, November 19, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, November 19, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, November 19, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

dehydratech powered molecules bioactive soluble oral topical increased drug spray delivery sustained